Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells

详细信息    查看全文

• 作者：Hyo Rim Ko ; Yun Sil Chang ; Won Soon Park and Jee-Yin Ahn
• 刊名：International Journal of Cancer
• 出版年：2016
• 出版时间：15 September 2016
• 年：2016
• 卷：139
• 期：6
• 页码：1202-1208
• 全文大小：426K
• ISSN：1097-0215

文摘

The different functions of the two isoforms of ErbB3 binding protein 1 (Ebp1), p48 and p42, have recently become the focus of interest as they reveal contradictory roles in cell growth promoting ability. The conformational change that crystal structure of p42 was shown to lack α helices at the amino-terminus present in p48 represents the differential binding partners and protein modifications of two Ebp1 isoforms. N-terminal specific phosphorylation by CDK2 and deregulation of the p53 tumor suppressor through specific interaction with HDM2 and Akt activation is postulated to contribute to p48-mediated tumorigenesis. The short isoform p42 Ebp1, which is actual binding partner of ErbB3 has been implicated as a tumor suppressor with many binding partners such as Rb, HDAC2, Sin3A and the p85 subunit of PI3K with HSP70/CHIP, inhibiting its own antiproliferative activity or inhibiting PI3K activity. The aim of the current review is to provide a summary on distinctive cellular functions of two Ebp1 proteins and their molecular partners that might be responsible for the unique functions of each isoform of Ebp1.